Home Healthcare Biotechnology Rare Biomarkers Specimen Collection and Stabilization Market

Rare Biomarkers Specimen Collection and Stabilization Market Size, Share & Trends Analysis Report By Type (Circulating Cell-Free DNA (ccfDNA), Circulating Tumor Cells (CTCs), Exosomes/Extracellular Vesicles), By Product (Isolation Kits & Reagents, Blood Collection Tubes, Systems), By Application (Non-Invasive Prenatal Testing (NIPT), Oncology, Pharmacogenomics, Transplant Rejection, Cardiovascular Diseases, Others), By End-Users (Hospitals, Perinatal Clinics, Diagnostics Laboratories, Research Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Rare Biomarkers Specimen Collection and Stabilization Market Size Analysis
    1. Introduction
    2. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Circulating Cell-Free DNA (ccfDNA)
      2. Circulating Tumor Cells (CTCs)
      3. Exosomes/Extracellular Vesicles
    3. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Isolation Kits & Reagents
      2. Blood Collection Tubes
      3. Systems
    4. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Non-Invasive Prenatal Testing (NIPT)
      2. Oncology
      3. Pharmacogenomics
      4. Transplant Rejection
      5. Cardiovascular Diseases
      6. Others
    5. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Perinatal Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
      5. Others
  7. North America Rare Biomarkers Specimen Collection and Stabilization Market Size Analysis
    1. Introduction
    2. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Circulating Cell-Free DNA (ccfDNA)
      2. Circulating Tumor Cells (CTCs)
      3. Exosomes/Extracellular Vesicles
    3. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Isolation Kits & Reagents
      2. Blood Collection Tubes
      3. Systems
    4. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Non-Invasive Prenatal Testing (NIPT)
      2. Oncology
      3. Pharmacogenomics
      4. Transplant Rejection
      5. Cardiovascular Diseases
      6. Others
    5. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Perinatal Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
      5. Others
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
  8. Europe Rare Biomarkers Specimen Collection and Stabilization Market Size Analysis
    1. Introduction
    2. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Circulating Cell-Free DNA (ccfDNA)
      2. Circulating Tumor Cells (CTCs)
      3. Exosomes/Extracellular Vesicles
    3. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Isolation Kits & Reagents
      2. Blood Collection Tubes
      3. Systems
    4. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Non-Invasive Prenatal Testing (NIPT)
      2. Oncology
      3. Pharmacogenomics
      4. Transplant Rejection
      5. Cardiovascular Diseases
      6. Others
    5. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Perinatal Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
      5. Others
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    8. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
  9. APAC Rare Biomarkers Specimen Collection and Stabilization Market Size Analysis
    1. Introduction
    2. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Circulating Cell-Free DNA (ccfDNA)
      2. Circulating Tumor Cells (CTCs)
      3. Exosomes/Extracellular Vesicles
    3. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Isolation Kits & Reagents
      2. Blood Collection Tubes
      3. Systems
    4. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Non-Invasive Prenatal Testing (NIPT)
      2. Oncology
      3. Pharmacogenomics
      4. Transplant Rejection
      5. Cardiovascular Diseases
      6. Others
    5. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Perinatal Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
      5. Others
    6. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    9. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
  10. Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market Size Analysis
    1. Introduction
    2. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Circulating Cell-Free DNA (ccfDNA)
      2. Circulating Tumor Cells (CTCs)
      3. Exosomes/Extracellular Vesicles
    3. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Isolation Kits & Reagents
      2. Blood Collection Tubes
      3. Systems
    4. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Non-Invasive Prenatal Testing (NIPT)
      2. Oncology
      3. Pharmacogenomics
      4. Transplant Rejection
      5. Cardiovascular Diseases
      6. Others
    5. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Perinatal Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
      5. Others
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
  11. LATAM Rare Biomarkers Specimen Collection and Stabilization Market Size Analysis
    1. Introduction
    2. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Circulating Cell-Free DNA (ccfDNA)
      2. Circulating Tumor Cells (CTCs)
      3. Exosomes/Extracellular Vesicles
    3. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Isolation Kits & Reagents
      2. Blood Collection Tubes
      3. Systems
    4. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Non-Invasive Prenatal Testing (NIPT)
      2. Oncology
      3. Pharmacogenomics
      4. Transplant Rejection
      5. Cardiovascular Diseases
      6. Others
    5. Rare Biomarkers Specimen Collection and Stabilization Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Perinatal Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
      5. Others
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
  12. Competitive Landscape
    1. Rare Biomarkers Specimen Collection and Stabilization Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Koneksa Health
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. QIAGEN
    3. Hoffmann-La Roche Ltd
    4. Thermo Fisher Scientific Inc.
    5. Eurofins Scientific
    6. Bio-Rad Laboratories, Inc.
    7. Agilent Technologies, Inc.
    8. Merck KGaA
    9. Siemens Healthcare Private Limited
    10. BD
    11. Illumina, Inc.
    12. Beckman Coulter, Inc.
    13. Oxford Nanopore Technologies plc.
    14. Guardant Health
    15. Avidity Bioscience
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.